Senior insider sale
Chief Medical Officer at TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$1.01M
26.21K shares
What this filing means
INRIG JULA plans to sell 26.21K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $1.01M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/4/2026ACC: 0001950047-26-000917
Officer· Chief Medical Officer
Since Jan 2022
26.21K
Shares to sell
$1.01M
Approx. market value
1.78K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Restricted Stock
Not Applicable
1/31/2026
1.78KTotal acquired1.78K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/31/2026 | Restricted Stock Not Applicable | 1.78K | — |
| Total | 1.78K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
6.96K
Market value
$223.4K
2/3/2026
—Completed
Units to sell
445.00
Market value
$16.8K
1/6/2026
—Completed
Units to sell
2.03K
Market value
$81.6K
1/5/2026
—Completed
Units to sell
15K
Market value
$630.0K
12/24/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.78K
Market value
$57.3K
2/4/2026
Total
Units
26.21K
Value
$1.01M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/3/2026 | 6.96K | $223.4K | — | Completed |
1/6/2026 | 445.00 | $16.8K | — | Completed |
1/5/2026 | 2.03K | $81.6K | — | Completed |
12/24/2025 | 15K | $630.0K | — | Completed |
| Planned — Approximate Date | ||||
2/4/2026 | 1.78K | $57.3K | NASDAQ | Planned |
| Total | 26.21K | $1.01M | ||